Image via Simply Wall St
Vertex Pharmaceuticals: Product Launch
Vertex Pharmaceuticals reported Phase 3 data for ALYFTREK showing improved CF function in children ages 2-5, and TRIKAFTA showing benefits in children ages 1-2. Company advanced nephrology pipeline with FDA acceptance of Biologics License Application for povetacicept in IgA nephropathy.
Source: Simply Wall St
The leadership read
Will need clinical development leaders, regulatory affairs specialists, pediatric clinical program managers, medical affairs professionals, and commercial launch teams for expanded age population indications and new nephrology programs
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Americas signal share is easing (-9.8pts).
MitchelLake in this thematic
Our work · 2020
Chief Technology Officer
Splitit
Americas · Fintech · payments · fintech
Our work · 2020
Senior Product Manager
Yanka Industries Inc. (Masterclass)
Americas · Sport, Media & Entertainment · product · edtech
Our work · 2019
Director of Product
Tubi, Inc.
Americas · Sport, Media & Entertainment · product · streaming